Selected article for: "available information and MERS cov"

Author: Bhattacharjee, Arghyadeep; Saha, Manish; Halder, Arpita; Debnath, Arka; Mukherjee, Oindrilla
Title: Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19
  • Cord-id: 1xtt92m4
  • Document date: 2021_1_3
  • ID: 1xtt92m4
    Snippet: The newly identified 2019 novel coronavirus (SARS-CoV-2) has become a public health concern globally posing a significant threat to human health and economy and creating an unprecedented crisis in all spheres of the global life. Emergence of new genotypes of SARS-CoV during the last few years has pointed out the limited efficacy of available vaccines and antivirals, constraining the global response to the COVID-19 outburst to largely monitoring/containment. There is high priority for treatment r
    Document: The newly identified 2019 novel coronavirus (SARS-CoV-2) has become a public health concern globally posing a significant threat to human health and economy and creating an unprecedented crisis in all spheres of the global life. Emergence of new genotypes of SARS-CoV during the last few years has pointed out the limited efficacy of available vaccines and antivirals, constraining the global response to the COVID-19 outburst to largely monitoring/containment. There is high priority for treatment regimes and new potential therapeutic and vaccine strategies. Several candidates have shown promising outcomes in various in vitro and in vivo models. In addition, clinical trials are in progress to test conceivable therapies showing promising outcomes in various in vivo studies. Unfortunately, very little information is available in the scientific scope which offers details to the diverse strategies being targeted to fight the pandemic, particularly with respect to the molecular targets. This review article summarizes and highlights the ongoing advances and approaches that are being carried out across the globe in designing vaccines and novel therapeutics, with particular reference to the previous knowledge gained from other viral infections like with the earlier SARS and MERS-CoV. A detailed knowledge may pave the way to combat this pandemic COVID-19 as well as prevent similar deadly epidemics in future.

    Search related documents:
    Co phrase search for related documents
    • absolute need and acute respiratory syndrome: 1
    • accessory protein and ace angiotensin converting enzyme: 1
    • accessory protein and acute chronic: 1
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
    • accessory protein and lung damage: 1
    • accessory protein and lung pathology: 1, 2
    • accessory protein and lung tissue: 1, 2
    • accessory structural and acute chronic: 1
    • accessory structural and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • accessory structural and macrophage colony: 1
    • accessory structural protein and acute respiratory syndrome: 1, 2, 3, 4, 5